Clik here to view.
How to Think About Higher Growth in Health-Care Spending
In this column for The Wall Street Journal's Think Tank, Drew Altman explains that just as we should not have expected historically low rates of health spending increases to continue, we should not...
View ArticleClik here to view.
The Connection Between Health Coverage and Income Security
In this column in The Wall Street Journal's Think Tank, Drew Altman shows how expanding health coverage and improving economic security for working Americans are connected even though they are often...
View ArticleClik here to view.
At CMS, the Mission Is Broader Than Medicare and Medicaid
In his latest column for The Wall Street Journal's Think Tank, Drew Altman discusses whether the Centers for Medicare and Medicaid Services' broad new responsibilities implementing the Affordable Care...
View ArticleClik here to view.
What Post-Katrina New Orleans Shows About Urban and Race Issues
Drew Altman discusses a growing racial divide in the city about perceptions of economic opportunity for blacks and whites and what progress and challenges in New Orleans may mean for urban America in...
View ArticleClik here to view.
Will GOP Candidates’ Positions on Obamacare Matter in Crowded Field?
In this column for The Wall Street Journal's Think Tank, Drew Altman analyzes the politics of Republican Affordable Care Act replacement plans and the challenges all Republican candidates will face...
View ArticleClik here to view.
Why Higher Drug Costs Are Consumers’ Biggest Cost Worry
In this column for The Wall Street Journal's Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health...
View ArticleClik here to view.
How Primary-Care Physicians Are Handling the Influx of Newly Insured
In this column for The Wall Street Journal's Think Tank, Kaiser’s President Drew Altman is joined by The Commonwealth Fund's President David Blumenthal to discuss the impact of the Affordable Care...
View ArticleClik here to view.
Why Consumer Issues Are Rising on the Health Agenda
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the trends that may be leading to a rise in consumer cost issues on the health agenda.
View ArticleClik here to view.
Two Substantive Sides to Debate Over Obamacare’s ‘Cadillac Tax’
In this column for The Wall Street Journal’s Think Tank, Drew Altman says debate about whether to keep or repeal the Cadillac tax is more than a debate between sound policy and good politics, there are...
View ArticleClik here to view.
Covering the Remaining Uninsured: Not Just a Red-State Issue
In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why covering the nation’s remaining uninsured population is more than just a red state issue.
View ArticleClik here to view.
The Good and Bad of Those Ubiquitous Drug Ads
In this column for The Wall Street Journal's Think Tank, Drew Altman examines the public’s mixed views about prescription drug ads and their impact on prescribing patterns, based on a new survey.
View ArticleClik here to view.
GOP Views of Medicaid Expansion Differ From Conventional Wisdom
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines Republican attitudes on Medicaid expansion in light of the election of Republican Matt Bevin as Kentucky’s next governor.
View ArticleClik here to view.
Health Care and the 2016 Debates
In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the lack of attention to health in the primary debates and last week's Democratic forum in South Carolina.
View ArticleClik here to view.
Why Painkiller Addiction and Abuse Are Rising Health-Care Priorities
In this column for The Wall Street Journal’s Think Tank, Drew Altman uses new polling to explore why painkiller abuse and addiction is rising as a health issue among state and federal policymakers.
View ArticleClik here to view.
What’s the Political Power of Those Newly Insured Under Obamacare?
In this column for The Wall Street Journal's Think Tank, Drew Altman takes a look at whether the 17 million people newly-insured since 2014 will make an impact in the first presidential election since...
View ArticleClik here to view.
Prescription Drugs’ Sizable Share of Health Spending
In this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look...
View ArticleClik here to view.
Bernie Sanders, Hillary Clinton, and Medicare for All
In this column for The Wall Street Journal’s Think Tank, Drew Altman explores the differing positions of presidential candidates Hillary Clinton and Bernie Sanders on a single payer or Medicare-for-all...
View ArticleClik here to view.
How High Drug Prices Weigh on the Sickest Americans
In this column for The Wall Street Journal's Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most...
View ArticleClik here to view.
How Health-Care Bills Hinder Millions of Americans
In this column for The Wall Street Journal’s Think Tank, Drew Altman examines the problems many Americans with health insurance are having paying medical bills based on a new Kaiser-New York Times...
View ArticleClik here to view.
In N.Y. Policy on Out-of-Network Medical Bills, a Model for Other States?
In this column for The Wall Street Journal's Think Tank, Drew Altman discusses surprise bills for out-of-network care, and New York state's solution to the problem.
View Article
